Institutional members access full text with Ovid®

Share this article on:

Strongyloides stercoralis Hyperinfection: A Therapeutic Challenge: Case Report and Review

Conci, Diego MD*; Stratidis, John G. MD

Infectious Diseases in Clinical Practice: September 2010 - Volume 18 - Issue 5 - p 304-307
doi: 10.1097/IPC.0b013e3181d654a7
Review Articles

Infection with Strongyloides stercoralis is a significant global public health problem. Hyperinfection syndrome occurs in immunocompromised hosts and is associated with chronic steroid therapy. If unrecognized, it is associated with significant morbidity and mortality. Available regimens for the treatment of S. stercoralis in humans include oral agents and infrequently subcutaneous formulations.

From the *Departments of Medicine and †Infectious Diseases, Danbury Hospital, Danbury, CT.

Correspondence to: John G. Stratidis, MD, Section of Infectious Diseases, Danbury Hospital, Danbury, CT. E-mail: john.stratidis@danhosp.org.

The authors have no funding or conflicts of interest to disclose.

© 2010 Lippincott Williams & Wilkins, Inc.